EP Souto, LE Dobrolecki, H Villanueva… - Journal of Mammary …, 2022 - Springer
Historically, human breast cancer has been modeled largely in vitro using long-established cell lines primarily in two-dimensional culture, but also in three-dimensional cultures of …
AN Boettcher, CL Loving, JE Cunnick… - Frontiers in oncology, 2018 - frontiersin.org
Within the last decade there have been several severe combined immunodeficient (SCID) pig models discovered or genetically engineered. The animals have mutations in ARTEMIS …
KN Murray, TS Clark, MJ Kebus, ML Kent - Research in veterinary science, 2022 - Elsevier
Specific pathogen-free (SPF) animals are bred and managed to exclude pathogens associated with significant morbidity or mortality that may secondarily pose a risk to public …
JL Miller, AP Bartlett, RM Harman, PD Majhi… - Journal of Mammary …, 2022 - Springer
Mammary cancer, or breast cancer in women, is a polygenic disease with a complex etiopathogenesis. While much remains elusive regarding its origin, it is well established that …
A Baehr, N Klymiuk, C Kupatt - International journal of molecular sciences, 2019 - mdpi.com
Coronary heart diseases are of high relevance for health care systems in developed countries regarding patient numbers and costs. Disappointingly, the enormous effort put into …
AN Boettcher, Y Li, AP Ahrens, M Kiupel… - Frontiers in …, 2020 - frontiersin.org
Pigs with severe combined immunodeficiency (SCID) are an emerging biomedical animal model. Swine are anatomically and physiologically more similar to humans than mice …
Background Severe combined immunodeficient (SCID) pigs are an emerging animal model being developed for biomedical and regenerative medicine research. SCID pigs can …
AN Boettcher, KM Schachtschneider, LB Schook… - Mammalian …, 2022 - Springer
Swine biomedical models have been gaining in popularity over the last decade, particularly for applications in oncology research. Swine models for cancer research include pigs that …
AN Boettcher, M Kiupel, MK Adur, E Cocco… - Frontiers in …, 2019 - frontiersin.org
Ovarian cancer (OvCa) is the most lethal gynecologic malignancy, with two-thirds of patients having late-stage disease (II-IV) at diagnosis. Improved diagnosis and therapies are …